Form 4: Liquidia CEO Roger Jeffs Executes Stock Sale Plan

Liquidia Corp CEO Roger Jeffs sold 75,000 shares of common stock through a pre-arranged Rule 10b5-1 trading plan.

Summary

• CEO Roger Jeffs sold a total of 75,000 shares of Liquidia Corp common stock between May 8, 2026, and May 12, 2026.
• The sales were executed in three tranches of 25,000 shares each at volume-weighted average prices of $42.14, $41.50, and $54.04 respectively.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.
• Following these transactions, the reporting person retains beneficial ownership of 1,273,095 shares held through Serendipity BioPharma LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; the sales were pre-planned and do not necessarily indicate a lack of confidence in the company's long-term prospects.

Positives

• The sales were executed under a pre-planned Rule 10b5-1 program, which is a standard mechanism for executives to sell stock without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the executive's direct and indirect equity stake in the company.

Risks

• Executive stock sales can sometimes be perceived negatively by the market as a signal of management's view on the company's near-term valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive selling via 10b5-1 plans is a routine corporate governance practice in the biopharmaceutical sector, often used to manage personal liquidity rather than reflecting a change in company fundamentals.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives at companies like United Therapeutics or MannKind to ensure compliance with SEC regulations while liquidating equity.

Related Party Transactions

• Shares are held by Serendipity BioPharma LLC, an entity managed by the reporting person.

Stakeholder Impact

• Shareholders should note the reduction in insider holdings, though the pre-planned nature mitigates concerns regarding sudden insider sentiment shifts.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Liquidia, LQDA, Insider Trading, Form 4, Roger Jeffs, Biopharma, Rule 10b5-1